MLLT1
| Gene Symbol | MLLT1 |
|---|---|
| Entrez Gene | 4298 |
| Alt Symbol | ENL, LTG19, YEATS1 |
| Species | Human |
| Gene Type | protein-coding |
| Description | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 |
| Other Description | CTC-503J8.6|ENL/MLL fusion|MLLT1/MLL fusion|YEATS domain-containing protein 1|myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog); translocated to, 1|protein ENL |
| Swissprots | Q14768 Q03111 |
| Accessions | EAW69106 Q03111 AF373587 AL365410 CAB96954 BC047008 BC063667 BC084564 BC146318 AAI46319 BC146385 AAI46386 BC148806 AAI48807 D14539 BAA03406 DQ224342 ABB29494 L04285 AAA58457 XM_011528021 XP_011526323 XM_011528022 XP_011526324 XM_011528023 XP_011526325 NM_005934 NP_005925 |
| Function | Component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948}. |
| Subcellular Location | Nucleus. |
| Top Pathways | Transcriptional misregulation in cancer |
Human MLLT1 full length protein - ab158901 from Abcam
|
||||||||||
ENL / MLLT1 Antibody Blocking Peptide - LS-E8117 from LifeSpan Bioscience
|
||||||||||
ENL / MLLT1 Antibody Blocking Peptide - LS-E11493 from LifeSpan Bioscience
|
||||||||||
Recombinant Human MLLT1 Protein - H00004298-P01 from Novus Biologicals
|
||||||||||
MLLT1 Peptide - P1796 from Novus Biologicals
|
||||||||||
MLLT1-Antibody-C-term-Blocking-Peptide - BP6188a from Abgent, a WuXi AppTec company
|
||||||||||
MLLT1 / ENL - H00004298-P01 from Acris Antibodies
|
||||||||||
MLLT1 / ENL - TP316754 from Acris Antibodies
|
||||||||||
MLLT1 Recombinant Protein Antigen - NBP1-84840PEP from Novus Biologicals
|
||||||||||
MLLT1 Peptide, Human - M34GP09568H from Creative Peptides
|